1. Impact of antidiabetic treatment with dipeptidyl peptidase-4 inhibitors on the risk of cardiac arrhythmias among patients with type 2 diabetes mellitus. (14th October 2021) Authors: Boulmpou, A; Patoulias, D; Teperikidis, E; Tsavousoglou, C; Vergopoulos, S; Toumpourleka, M; Doumas, M; Fragakis, N; Vassilikos, V; Papadopoulos, C E Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Meta-analysis of cardiovascular outcome trials assessing the cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus. (14th October 2021) Authors: Patoulias, D; Boulmpou, A; Teperikidis, E; Katsimardou, A; Siskos, F; Tranidou, A; Nikolaidis, A; Mouselimis, D; Doumas, M; Papadopoulos, C E; Vassilikos, V Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Meta-analysis of cardiovascular outcome trials assessing the impact of glucagon-like peptide-1 receptor agonists on major cardiac arrhythmias. (14th October 2021) Authors: Boulmpou, A; Patoulias, D; Teperikidis, E; Toumpourleka, M; Vergopoulos, S; Tsavousoglou, C; Doumas, M; Fragakis, N; Vassilikos, V; Papadopoulos, C E Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Sodium-glucose co-transporter-2 inhibitors and the risk of major arrhythmias: a meta-analysis of the cardiovascular and renal outcome trials. (14th October 2021) Authors: Boulmpou, A; Patoulias, D; Teperikidis, E; Papadopoulos, C E; Sarafidis, P; Doumas, M; Fragakis, N; Pagourelias, E; Vassilikos, V Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗